미국의 두개악안면 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 재료별, 용도별, 부문별 예측(2023-2030년)

U.S. Craniomaxillofacial Devices Market Growth & Trends:

The U.S. craniomaxillofacial devices market size is expected to reach USD 2.15 billion by 2030, expanding at a CAGR of 9.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of facial fractures due to sports injuries and road accidents, and increasing aesthetic consciousness are the key factors driving the product demand. The demand for Temporomandibular Joint Replacement is projected to witness a rise during the forecast period due to high adoption.

When a patient needs face or cranial bone surgery because of trauma-related fractures or other craniomaxillofacial injuries, they frequently undergo craniomaxillofacial surgery. Craniomaxillofacial devices are used in aesthetics and facial reconstruction. The devices mostly find application in neurosurgery, orthognathic and dental surgery, and plastic surgery.

The COVID-19 outbreak had a detrimental effect on the market for CMF devices since the manufacturers of products for elective procedures saw a significant drop in sales, as a result of production slowdown, a reduction in working hours, and layoffs. The COVID-19 problem had the greatest effect on the neurological product line. Due to the suspension of non-essential surgeries, orders were delayed and consumable sales were decreased. Covid Care Centers were created to house plastic surgeons, and only emergencies were treated with plastic surgery.

However, the post-pandemic period has seen a good recovery looking at the sales revenue generated by the companies. For instance, according to Johnson and Johnson financial report 2021, In all of its businesses, including Surgery, Interventional Solutions, Vision, and Orthopaedics, Medical Devices worldwide adjusted operational sales increased by 16.8%, mainly attributable to the market's recovery from COVID-19 impacts and the resulting postponement of medical procedures in the prior year.

U.S. Craniomaxillofacial Devices Market Report Highlights:

• CMF Plate and Screw fixation devices emerged as the largest product type segment in 2022 accounting for the largest revenue share of over 70%
• Bioabsorbable materials are anticipated to be the fastest-growing material segment over the forecast period
• Some of the key players operating in the market include Stryker Corporation; Medtronic Plc; KLS Martin L.P; Medartis AG; Johnson & Johnson; W. L. Gore & Associates, Inc; TMJ Concepts; Integra LifeSciences; OsteoMed L.P.; Aesculap Implant Systems, Inc; Zimmer-Biomet Inc.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Material
  • 1.1.3. Application
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Material outlook
  • 2.2.3. Application outlook
• 2.3. Competitive Insights

Chapter 3. Craniomaxillofacial Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Craniomaxillofacial Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Craniomaxillofacial Devices : Product Estimates & Trend Analysis

• 4.1. Craniomaxillofacial Devices Market: Key Takeaways
• 4.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Cranial Flap Fixation
  • 4.3.1. Cranial flap fixation market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. CMF Distraction
  • 4.4.1. CMF distraction market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Temporomandibular Joint Replacement
  • 4.5.1. Temporomandibular joint replacement market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Thoracic Fixation
  • 4.6.1. Thoracic fixation market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Bone Graft Substitute
  • 4.7.1. Bone graft substitute market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.8. CMF Plate and Screw Fixation
  • 4.8.1. CMF plate and screw fixation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Craniomaxillofacial Devices : Material Estimates & Trend Analysis

• 5.1. Craniomaxillofacial Devices Market: Key Takeaways
• 5.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Metal
  • 5.3.1. Metal market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Bioabsorbable material
  • 5.4.1. Bioabsorbable material market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Ceramics
  • 5.5.1. Ceramics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Craniomaxillofacial Devices : Application Estimates & Trend Analysis

• 6.1. Craniomaxillofacial Devices Market: Key Takeaways
• 6.2. Craniomaxillofacial Devices Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Neurosurgery
  • 6.3.1. Neurosurgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Orthognathic and Dental Surgery
  • 6.4.1. Orthognathic and dental surgery market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Plastic surgery
  • 6.5.1. Plastic surgery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Market Participant Categorization
  • 7.2.1. Stryker Corporation
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Medtronic Plc
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. KLS Martin Group
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Medartis AG
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Johnson & Johnson
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. W. L. Gore & Associates, Inc.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. TMJ Concepts
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Integra LifeSciences
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. OsteoMed L.P.
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Aesculap Implant Systems, LLC
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Zimmer Biomet Inc.
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives